Literature DB >> 2447428

Actions of nicorandil on vascular smooth muscles.

K Sumimoto1, M Domae, K Yamanaka, K Nakao, T Hashimoto, K Kitamura, H Kuriyama.   

Abstract

The action of nicorandil on vascular smooth muscles has been studied in vitro using the microelectrode, Ca-transient, isometric tension recording methods, and the bioassay methods of cyclic nucleotides and inositol phospholipids. Nicorandil increased Ca-insensitive K conductance and hyperpolarized the membrane and thus prevented the activation of the voltage-dependent Ca channel. The hyperpolarization occurred to a greater extent in venous tissue than in arterial tissue. Nicorandil stimulated the synthesis of cyclic guanosine monophosphate (cGMP) in the polarized and depolarized muscle tissues, as did nitroglycerin. Consequently, nicorandil reduces the concentrations of free Ca in the myoplasm, due to acceleration of the Ca pump at the sarcolemma, and may prevent the phosphorylation of myosin through phosphorylation of myosin light chain kinase. These actions of nicorandil may not contribute to the synthesis of inositol-1,4,5-trisphosphate hydrolyzed from phosphatidylinositol-4,5-bisphosphate. The above actions of nicorandil--hyperpolarization and increase in the cyclic GMP--may cause relaxation of the tissues precontracted by various stimulants.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2447428

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  11 in total

1.  Factors inducing endothelium-dependent relaxation in the guinea-pig basilar artery as estimated from the actions of haemoglobin.

Authors:  E Nishiye; K Nakao; T Itoh; H Kuriyama
Journal:  Br J Pharmacol       Date:  1989-03       Impact factor: 8.739

Review 2.  Nicorandil and Long-acting Nitrates: Vasodilator Therapies for the Management of Chronic Stable Angina Pectoris.

Authors:  Jason M Tarkin; Juan Carlos Kaski
Journal:  Eur Cardiol       Date:  2018-08

3.  Effect of the potassium-channel opener nicorandil as an adjunct to cardioplegia on myocardial preservation in isolated rabbit hearts.

Authors:  Y Wang; M Sunamori; T Yoshida
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

Review 4.  K channel openers activate different K channels in vascular smooth muscle cells.

Authors:  K Kitamura; M Kamouchi
Journal:  Cardiovasc Drugs Ther       Date:  1993-08       Impact factor: 3.727

5.  Front-surface fluorometry with fura-2 and effects of nitroglycerin on cytosolic calcium concentrations and on tension in the coronary artery of the pig.

Authors:  S Abe; H Kanaide; M Nakamura
Journal:  Br J Pharmacol       Date:  1990-11       Impact factor: 8.739

6.  Actions of second messengers synthesized by various spasmogenic agents and their relation to mechanical responses in dog tracheal smooth muscle.

Authors:  H Katsuyama; S Suzuki; E Nishiye
Journal:  Br J Pharmacol       Date:  1990-05       Impact factor: 8.739

7.  Comparison of cromakalim-induced relaxation of potassium precontracted rabbit, cat, and rat isolated cerebral arteries.

Authors:  A A Parsons; E Ksoll; J R Mackert; L Schilling; M Wahl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-04       Impact factor: 3.000

8.  The effect of relaxants working through different transduction mechanisms on the tonic contraction produced in rat aorta by 4 beta-phorbol dibutyrate.

Authors:  A W Obianime; M M Dale
Journal:  Br J Pharmacol       Date:  1989-07       Impact factor: 8.739

9.  Comparison of the development of tolerance to nitroglycerin in aortic preparations isolated from non-diabetic and diabetic rats.

Authors:  T Matsuzaki; M Sakanashi
Journal:  Heart Vessels       Date:  1992       Impact factor: 2.037

10.  Analysis of cromakalim-, pinacidil-, and nicorandil-induced relaxation of the 5-hydroxytryptamine precontracted rat isolated basilar artery.

Authors:  E Ksoll; A A Parsons; J R Mackert; L Schilling; M Wahl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-04       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.